Cape Cod Five Cents Savings Bank reduced its stake in shares of Zimmer Biomet Holdings Inc (NYSE:ZBH) by 0.6% during the first quarter, Holdings Channel reports. The institutional investor owned 6,127 shares of the medical equipment provider’s stock after selling 40 shares during the period. Cape Cod Five Cents Savings Bank’s holdings in Zimmer Biomet Holdings were worth $748,000 as of its most recent filing with the SEC.

Several other large investors have also bought and sold shares of the stock. Parkwood LLC purchased a new position in Zimmer Biomet Holdings during the third quarter valued at approximately $281,000. Gilman Hill Asset Management LLC raised its position in Zimmer Biomet Holdings by 28.1% in the third quarter. Gilman Hill Asset Management LLC now owns 3,710 shares of the medical equipment provider’s stock valued at $482,000 after buying an additional 814 shares during the period. Sumitomo Life Insurance Co. raised its position in Zimmer Biomet Holdings by 46.9% in the third quarter. Sumitomo Life Insurance Co. now owns 11,719 shares of the medical equipment provider’s stock valued at $1,524,000 after buying an additional 3,740 shares during the period. Boston Advisors LLC raised its position in Zimmer Biomet Holdings by 679.9% in the third quarter. Boston Advisors LLC now owns 17,212 shares of the medical equipment provider’s stock valued at $2,238,000 after buying an additional 15,005 shares during the period. Finally, Conning Inc. raised its position in Zimmer Biomet Holdings by 8.9% in the third quarter. Conning Inc. now owns 4,656 shares of the medical equipment provider’s stock valued at $605,000 after buying an additional 380 shares during the period. Institutional investors and hedge funds own 86.62% of the company’s stock.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Zimmer Biomet Holdings Inc (NYSE:ZBH) traded down 0.54% during mid-day trading on Friday, hitting $121.19. 814,241 shares of the stock traded hands. Zimmer Biomet Holdings Inc has a 12-month low of $95.63 and a 12-month high of $133.21. The company has a 50 day moving average of $120.04 and a 200-day moving average of $114.18. The stock has a market cap of $24.37 billion, a PE ratio of 80.26 and a beta of 1.20.

Zimmer Biomet Holdings (NYSE:ZBH) last issued its earnings results on Tuesday, January 31st. The medical equipment provider reported $2.14 EPS for the quarter, topping the consensus estimate of $2.11 by $0.03. The company had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.98 billion. Zimmer Biomet Holdings had a net margin of 3.90% and a return on equity of 16.66%. The business’s revenue was up 4.1% on a year-over-year basis. During the same period in the previous year, the firm earned $2.09 EPS. Equities research analysts forecast that Zimmer Biomet Holdings Inc will post $8.59 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, April 28th. Shareholders of record on Friday, March 31st will be given a dividend of $0.24 per share. The ex-dividend date is Wednesday, March 29th. This represents a $0.96 annualized dividend and a dividend yield of 0.79%. Zimmer Biomet Holdings’s payout ratio is currently 65.31%.

TRADEMARK VIOLATION WARNING: “Cape Cod Five Cents Savings Bank Sells 40 Shares of Zimmer Biomet Holdings Inc (ZBH)” was first reported by Financial Market News and is owned by of Financial Market News. If you are viewing this report on another website, it was copied illegally and republished in violation of United States and international copyright law. The correct version of this report can be viewed at https://www.financial-market-news.com/2017/04/21/cape-cod-five-cents-savings-bank-sells-40-shares-of-zimmer-biomet-holdings-inc-zbh.html.

ZBH has been the subject of several recent analyst reports. JPMorgan Chase & Co. set a $134.00 price objective on shares of Zimmer Biomet Holdings and gave the stock a “buy” rating in a research note on Thursday, January 5th. Canaccord Genuity set a $130.00 price objective on shares of Zimmer Biomet Holdings and gave the stock a “buy” rating in a research note on Monday, January 23rd. Needham & Company LLC boosted their price objective on shares of Zimmer Biomet Holdings from $148.00 to $151.00 and gave the stock a “strong-buy” rating in a research note on Wednesday, January 25th. Royal Bank of Canada boosted their price objective on shares of Zimmer Biomet Holdings from $130.00 to $133.00 and gave the stock an “outperform” rating in a research note on Wednesday, February 1st. Finally, Robert W. Baird reiterated an “outperform” rating and set a $136.00 price objective (up previously from $130.00) on shares of Zimmer Biomet Holdings in a research note on Wednesday, February 1st. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $136.31.

In other Zimmer Biomet Holdings news, insider David C. Dvorak sold 1,040 shares of the business’s stock in a transaction on Monday, March 20th. The shares were sold at an average price of $121.63, for a total transaction of $126,495.20. Following the sale, the insider now directly owns 294,077 shares in the company, valued at approximately $35,768,585.51. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.22% of the stock is currently owned by insiders.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

5 Day Chart for NYSE:ZBH

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings Inc (NYSE:ZBH).

Receive News & Ratings for Zimmer Biomet Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.